Cargando…
Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer
BACKGROUND: In recent years, numerous studies have investigated somatic mutations in mitochondrial DNA in various tumours. The observed high mutation rates might reflect mitochondrial deregulation; consequently, mutation analyses could be clinically relevant. The purpose of this study was to determi...
Autores principales: | Bragoszewski, Piotr, Kupryjanczyk, Jolanta, Bartnik, Ewa, Rachinger, Andrea, Ostrowski, Jerzy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571110/ https://www.ncbi.nlm.nih.gov/pubmed/18842121 http://dx.doi.org/10.1186/1471-2407-8-292 |
Ejemplares similares
-
Nuclear genes involved in mitochondrial diseases caused by instability of mitochondrial DNA
por: Rusecka, Joanna, et al.
Publicado: (2018) -
Control of mitochondrial biogenesis and function by the ubiquitin–proteasome system
por: Bragoszewski, Piotr, et al.
Publicado: (2017) -
Gene Expression Analysis in Ovarian Cancer – Faults and Hints from DNA Microarray Study
por: Lisowska, Katarzyna Marta, et al.
Publicado: (2014) -
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
por: Kupryjanczyk, Jolanta, et al.
Publicado: (2008) -
Evaluation of selected ultrasonographic parameters and marker levels in the preoperative differentiation of borderline ovarian tumors and ovarian cancers
por: Sobiczewski, Piotr, et al.
Publicado: (2012)